Publications by authors named "Johan van Beek"

Claim this Profile
C
Characterizing gait in people with multiple sclerosis using digital data from smartphone sensors: A proposed framework.
Angelos Karatsidis, Lorenza Angelini, Matthew Scaramozza, Emmanuel Bartholome, Susanne P Clinch, Johan van Beek

Mult Scler· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world datasets for the International Registry for Alzheimer's Disease and Other Dementias (InRAD) and other registries: An international consensus.
Robert Perneczky, David Darby, Giovanni B Frisoni, Robert Hyde, Takeshi Iwatsubo, Johan van Beek

J Prev Alzheimers Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Trajectories of Digital Cognitive Biomarkers for Multiple Sclerosis.
Yi Chao Foong, Daniel Merlo, Melissa Gresle, Chao Zhu, Katherine Buzzard, Johan van Beek

Ann Clin Transl Neurol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A digital version of the nine-hole peg test: Speed may be a more reliable measure of upper-limb disability than completion time in patients with multiple sclerosis.
Xiaotong Jiang, Marisa McGinley, Joshua Johnston, Jay Alberts, Robert Bermel, Johan van Beek

Mult Scler· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal trajectories of digital upper limb biomarkers for multiple sclerosis.
Yi Chao Foong, Daniel Merlo, Melissa Gresle, Chao Zhu, Katherine Buzzard, Johan van Beek

Eur J Neurol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensor-Derived Measures of Motor and Cognitive Functions in People With Multiple Sclerosis Using Unsupervised Smartphone-Based Assessments: Proof-of-Concept Study.
Matthew Scaramozza, Aurélie Ruet, Patrizia A Chiesa, Laïtissia Ahamada, Emmanuel Bartholomé, Johan van Beek

JMIR Form Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Patient-Determined Disease Steps scale is not interchangeable with the Expanded Disease Status Scale in mild to moderate multiple sclerosis.
Yi Chao Foong, Daniel Merlo, Melissa Gresle, Chao Zhu, Katherine Buzzard, Johan van Beek

Eur J Neurol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of smartphone-based remote assessments of multiple sclerosis in Floodlight Open, a global, prospective, open-access study.
Jiwon Oh, Luca Capezzuto, Lito Kriara, Jens Schjodt-Eriksen, Johan van Beek

Sci Rep· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary validity of the Draw a Shape Test for upper extremity assessment in multiple sclerosis.
Jennifer S Graves, Marco Ganzetti, Frank Dondelinger, Florian Lipsmeier, Shibeshih Belachew, Johan van Beek

Ann Clin Transl Neurol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocrelizumab reduces thalamic volume loss in patients with RMS and PPMS.
Douglas L Arnold, Till Sprenger, Amit Bar-Or, Jerry S Wolinsky, Ludwig Kappos, Johan van Beek

Mult Scler· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A smartphone sensor-based digital outcome assessment of multiple sclerosis.
Xavier Montalban, Jennifer Graves, Luciana Midaglia, Patricia Mulero, Laura Julian, Johan van Beek

Mult Scler· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prioritizing progressive MS rehabilitation research: A call from the International Progressive MS Alliance.
Kathleen M Zackowski, Jennifer Freeman, Giampaolo Brichetto, Diego Centonze, Ulrik Dalgas, Johan van Beek

Mult Scler· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smartphone- and Smartwatch-Based Remote Characterisation of Ambulation in Multiple Sclerosis During the Two-Minute Walk Test.
Andrew P Creagh, Cedric Simillion, Alan K Bourke, Alf Scotland, Florian Lipsmeier, Johan van Beek

IEEE J Biomed Health Inform· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study.
Luciana Midaglia, Patricia Mulero, Xavier Montalban, Jennifer Graves, Stephen L Hauser, Johan van Beek

J Med Internet Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study.
Luciana Midaglia, Patricia Mulero, Xavier Montalban, Jennifer Graves, Stephen L Hauser, Johan van Beek

J Med Internet Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PREFERENCES OF PATIENTS WITH MULTIPLE SCLEROSIS FOR ATTRIBUTES OF INJECTABLE MULTIPLE SCLEROSIS TREATMENTS IN THE UNITED KINGDOM AND FRANCE.
Christine Poulos, Elizabeth Kinter, Johan van Beek, Katrine Christensen, Joshua Posner

Int J Technol Assess Health Care· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATON: results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis.
Robert C Sergott, Jeffrey L Bennett, Peter Rieckmann, Xavier Montalban, Daniel Mikol, Johan van Beek

J Neurol Sci· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial.
Ludwig Kappos, Hans-Peter Hartung, Mark S Freedman, Alexey Boyko, Ernst Wilhelm Radü, Johan van Beek

Lancet Neurol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nest building performance following MPTP toxicity in mice.
Thomas Nikolaj Sager, Jeppe Kirchhoff, Arne Mørk, Johan Van Beek, Kenneth Thirstrup

Behav Brain Res· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular basis for detection of invading pathogens in the brain.
Jeppe Falsig, Johan van Beek, Corinna Hermann, Marcel Leist

J Neurosci Res· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional and immunochemical characterisation of different antibodies against the erythropoietin receptor.
Agnete Kirkeby, Johan van Beek, Jacob Nielsen, Marcel Leist, Lone Helboe

J Neurosci Methods· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation in Parkinson's disease: causative or epiphenomenal?
Andreas Hald, Johan Van Beek, Julie Lotharius

Subcell Biochem· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures.
Maria Montero, Frantz Rom Poulsen, Jens Noraberg, Agnete Kirkeby, Johan van Beek

Exp Neurol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence of Oatp and Mdr1 in cryopreserved rat hepatocytes.
Lene Jørgensen, Johan Van Beek, Søren Lund, Arne Schousboe, Lassina Badolo

Eur J Pharm Sci· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonhematopoietic erythropoietin derivatives prevent motoneuron degeneration in vitro and in vivo.
Tiziana Mennini, Massimiliano De Paola, Paolo Bigini, Cristina Mastrotto, Elena Fumagalli, Johan Van Beek

Mol Med· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis